Logo image of OGI

ORGANIGRAM GLOBAL INC (OGI) Stock Fundamental Analysis

USA - NASDAQ:OGI - CA68617J1003 - Common Stock

2.03 USD
+0.06 (+3.05%)
Last: 9/30/2025, 8:00:02 PM
2.0202 USD
-0.01 (-0.48%)
After Hours: 9/30/2025, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OGI. OGI was compared to 196 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of OGI have multiple concerns. OGI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year OGI has reported negative net income.
OGI had a positive operating cash flow in the past year.
OGI had negative earnings in each of the past 5 years.
In the past 5 years OGI reported 4 times negative operating cash flow.
OGI Yearly Net Income VS EBIT VS OCF VS FCFOGI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

OGI's Return On Assets of 1.38% is amongst the best of the industry. OGI outperforms 83.16% of its industry peers.
The Return On Equity of OGI (2.02%) is better than 83.16% of its industry peers.
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROIC N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
OGI Yearly ROA, ROE, ROICOGI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Profit Margin, with a value of 3.47%, OGI belongs to the top of the industry, outperforming 82.65% of the companies in the same industry.
OGI does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 3.47%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OGI Yearly Profit, Operating, Gross MarginsOGI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

OGI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OGI has more shares outstanding
Compared to 5 years ago, OGI has more shares outstanding
The debt/assets ratio for OGI is higher compared to a year ago.
OGI Yearly Shares OutstandingOGI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
OGI Yearly Total Debt VS Total AssetsOGI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -0.17, we must say that OGI is in the distress zone and has some risk of bankruptcy.
OGI's Altman-Z score of -0.17 is in line compared to the rest of the industry. OGI outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that OGI is not too dependend on debt financing.
The Debt to Equity ratio of OGI (0.14) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -0.17
ROIC/WACCN/A
WACC9.07%
OGI Yearly LT Debt VS Equity VS FCFOGI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

OGI has a Current Ratio of 2.59. This indicates that OGI is financially healthy and has no problem in meeting its short term obligations.
OGI's Current ratio of 2.59 is in line compared to the rest of the industry. OGI outperforms 47.96% of its industry peers.
A Quick Ratio of 1.42 indicates that OGI should not have too much problems paying its short term obligations.
OGI's Quick ratio of 1.42 is on the low side compared to the rest of the industry. OGI is outperformed by 61.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.59
Quick Ratio 1.42
OGI Yearly Current Assets VS Current LiabilitesOGI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

6

3. Growth

3.1 Past

OGI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.88%, which is quite impressive.
Looking at the last year, OGI shows a very strong growth in Revenue. The Revenue has grown by 38.86%.
OGI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%

3.2 Future

The Earnings Per Share is expected to grow by 19.86% on average over the next years. This is quite good.
Based on estimates for the next years, OGI will show a quite strong growth in Revenue. The Revenue will grow by 17.78% on average per year.
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.86%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y17.78%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGI Yearly Revenue VS EstimatesOGI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
OGI Yearly EPS VS EstimatesOGI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Forward Earnings ratio is 1400.14, which means the current valuation is very expensive for OGI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OGI indicates a somewhat cheap valuation: OGI is cheaper than 65.82% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.18. OGI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1400.14
OGI Price Earnings VS Forward Price EarningsOGI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OGI Per share dataOGI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates OGI does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as OGI's earnings are expected to grow with 28.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.59%
EPS Next 3Y28.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OGI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORGANIGRAM GLOBAL INC

NASDAQ:OGI (9/30/2025, 8:00:02 PM)

After market: 2.0202 -0.01 (-0.48%)

2.03

+0.06 (+3.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)12-16 2025-12-16/amc
Inst Owners6.05%
Inst Owner Change18.4%
Ins Owners2.53%
Ins Owner ChangeN/A
Market Cap272.69M
Analysts77.5
Price Target2.22 (9.36%)
Short Float %5.81%
Short Ratio6.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)376.4%
Min EPS beat(2)-164.03%
Max EPS beat(2)916.83%
EPS beat(4)1
Avg EPS beat(4)56.27%
Min EPS beat(4)-400%
Max EPS beat(4)916.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.51%
Min Revenue beat(2)3.01%
Max Revenue beat(2)6%
Revenue beat(4)3
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-12.23%
Max Revenue beat(4)6%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)6
Avg Revenue beat(12)-1.43%
Revenue beat(16)9
Avg Revenue beat(16)0.17%
PT rev (1m)0.04%
PT rev (3m)7.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)138.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.9%
Revenue NY rev (1m)0.73%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1400.14
P/S 1.7
P/FCF N/A
P/OCF 137.95
P/B 0.99
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0
Fwd EY0.07%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.01
OCFY0.72%
SpS1.2
BVpS2.06
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 2.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.47%
GM N/A
FCFM N/A
ROA(3y)-32.3%
ROA(5y)-30.36%
ROE(3y)-36.4%
ROE(5y)-36.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 122.48%
Cap/Sales 8.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.59
Quick Ratio 1.42
Altman-Z -0.17
F-Score3
WACC9.07%
ROIC/WACCN/A
Cap/Depr(3y)118.74%
Cap/Depr(5y)166.77%
Cap/Sales(3y)18.54%
Cap/Sales(5y)32.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-253.85%
EPS Next Y119.5%
EPS Next 2Y41.59%
EPS Next 3Y28.91%
EPS Next 5Y19.86%
Revenue 1Y (TTM)38.86%
Revenue growth 3Y26.37%
Revenue growth 5Y14.73%
Sales Q2Q%72.41%
Revenue Next Year57.11%
Revenue Next 2Y34.49%
Revenue Next 3Y26.71%
Revenue Next 5Y17.78%
EBIT growth 1Y-79.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.17%
EBIT Next 3Y46.25%
EBIT Next 5Y30.42%
FCF growth 1Y78.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.64%
OCF growth 3YN/A
OCF growth 5YN/A